CRISPR Therapeutics AG
CRSP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$366 | -$154 | -$650 | $378 |
| Dep. & Amort. | $19 | $20 | $24 | $18 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $87 | $0 | $98 | $102 |
| Change in WC | $156 | -$194 | $20 | $27 |
| Other Non-Cash | -$39 | $67 | $12 | $14 |
| Operating Cash Flow | -$143 | -$260 | -$496 | $539 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$9 | -$37 | -$82 |
| Net Acquisitions | $0 | $0 | $221 | $954 |
| Inv. Purchases | -$1,486 | -$1,066 | -$1,418 | -$1,509 |
| Inv. Sales/Matur. | $1,208 | $1,453 | $1,196 | $556 |
| Other Inv. Act. | $0 | -$3 | -$221 | -$954 |
| Investing Cash Flow | -$280 | $375 | -$259 | -$1,035 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $301 | $63 | $1 | $213 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $31 | $0 | $38 | $38 |
| Financing Cash Flow | $332 | $63 | $39 | $251 |
| Forex Effect | -$0 | $1 | -$0 | -$0 |
| Net Chg. in Cash | -$91 | $178 | -$716 | -$246 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $401 | $212 | $940 | $1,185 |
| End Cash | $310 | $389 | $224 | $940 |
| Free Cash Flow | -$145 | -$270 | -$533 | $457 |